Bosutinib Active Not Recruiting Phase 3 Trials for Philadelphia Chromosome Positive (Ph+) Chronic Myeloid Leukemia (CML) Treatment

IndicationsStatusPurposePhase
Active Not RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04971226A Study of Oral Asciminib Versus Other TKIs in Adult Patients With Newly Diagnosed Ph+ CML-CP